8 companies

Showing 1–8 of 8 companies

Isomorphic Labs

Isomorphic Labs is a British AI drug discovery company, spun out of Google DeepMind in 2021, using AI to model biology, design molecules and develop medicines in oncology and immunology.

1 open job

Aqemia

Aqemia invents novel drug molecules using its QEMI platform, which combines physics-based modeling, statistical mechanics and generative AI to design candidates without experimental data.

1 open job

Parallel Bio

Parallel Bio combines a scalable human immune organoid with AI to generate population-scale human biological data for drug discovery, reporting 87% concordance with clinical data.

2 open jobs

Biorelate

Biorelate is an AI company, founded in 2014 and based in Manchester, whose Galactic AI platform curates biomedical knowledge from scientific documents into knowledge graphs for pharma and life sciences teams.

Tangram Therapeutics

Tangram Therapeutics is a biotechnology company using AI and RNAi to develop genetic medicines.

1 open job

Monte Rosa Therapeutics

Monte Rosa Therapeutics develops clinical-stage molecular glue degrader medicines using an AI-guided discovery engine targeting undruggable proteins.

1 open job

Proteros Biostructures GmbH

Proteros Biostructures GmbH provides structure-based early stage drug discovery services, combining protein sciences, structural biology, biophysics and screening for challenging targets.

1 open job

Immunai

Immunai is a biotech company using AI and single-cell multiomics to decode the human immune system and accelerate drug discovery for pharmaceutical partners.

8 companies

Isomorphic Labs

Aqemia

Parallel Bio

Biorelate

Tangram Therapeutics

Monte Rosa Therapeutics

Proteros Biostructures GmbH

Immunai

Browse by market